<DOC>
	<DOCNO>NCT01055743</DOCNO>
	<brief_summary>This study assess clinical efficacy safety fluorouracil implant regional chemotherapy surgical treatment early-stage hepatocellular carcinoma .</brief_summary>
	<brief_title>The Effect Fluorouracil Implants Regional Chemotherapy During Surgical Treatment Early Stage Hepatocellular Carcinoma</brief_title>
	<detailed_description />
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Carcinoma , Hepatocellular</mesh_term>
	<mesh_term>Fluorouracil</mesh_term>
	<criteria>Histological diagnosis stage I hepatocellular carcinoma ChildPugh class A , B Radical resection feasible Patients adequate renal , hepatic , hematologic function Written inform consent Allergic chemotherapy drug No measurable lesion Receive chemotherapy , radiotherapy biotherapy within 30 day prior enrollment Evidence serious infection Renal hepatic dysfunction , significant cardiovascular disease Pregnant lactating woman</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>January 2010</verification_date>
	<keyword>Fluorouracil Implants</keyword>
	<keyword>Hepatocellular carcinoma</keyword>
	<keyword>Radical resection</keyword>
</DOC>